Vaccinex, Inc. (VCNX)
USD 0.5
(-16.67%)
USD 0.5
(-16.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 570 Thousand | 100 Thousand | 900 Thousand | 50 Thousand | 523 Thousand | 724 Thousand |
| Cost of Revenue | 16.57 Million | 207 Thousand | 169 Thousand | 2000.00 | 199 Thousand | 1.03 Million |
| Gross Profit | -16 Million | -107 Thousand | 731 Thousand | 48 Thousand | 324 Thousand | -309 Thousand |
| Operating Expenses | 23.45 Million | 20 Million | 23.39 Million | 28.37 Million | 32.33 Million | 26.97 Million |
| Selling, General and Administrative Expenses | 6.88 Million | 6.2 Million | 6.23 Million | 7.4 Million | 6.66 Million | 4.61 Million |
| Research and Development Expenses | 16.57 Million | 13.97 Million | 17.16 Million | 21.54 Million | 25.67 Million | 22.35 Million |
| Other Expenses | - | -175 Thousand | 43 Thousand | -575 Thousand | 152 Thousand | 165 Thousand |
| Cost and Expenses | 23.45 Million | 20 Million | 23.39 Million | 28.38 Million | 32.53 Million | 28 Million |
| Operating Income | -22.88 Million | -19.9 Million | -22.49 Million | -28.33 Million | -32.01 Million | -27.28 Million |
| Interest Expense | 1000.00 | 2000.00 | 809 Thousand | 489 Thousand | - | 392 Thousand |
| Income Tax Expense | - | -93 Thousand | 852 Thousand | 458 Thousand | 152 Thousand | -1.84 Million |
| Earnings before Tax | -20.25 Million | -19.81 Million | -22.38 Million | -28.85 Million | -31.86 Million | -29.51 Million |
| Net Income | -20.25 Million | -19.72 Million | -23.23 Million | -29.3 Million | -32.01 Million | -29.51 Million |
| Earnings Per Share Basic | -43.68 | -97.59 | -170.04 | -327.62 | -521.95 | -1186.70 |
| Earnings Per Share Diluted | -43.68 | -97.59 | -169.11 | -327.62 | -521.95 | -1186.70 |
| Weighted Average Shares Outstanding | 463.65 Thousand | 202.08 Thousand | 136.63 Thousand | 89.46 Thousand | 61.33 Thousand | 24.87 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 463.65 Thousand | 202.08 Thousand | 137.37 Thousand | 89.46 Thousand | 61.33 Thousand | 24.87 Thousand |
| Gross Margin | -28.08 | -1.07 | 0.81 | 0.96 | 0.62 | -0.43 |
| EBIT Margin | -34.65 | -196.06 | -24.75 | -561.10 | -60.45 | -37.15 |
| Profit Margin | -35.53 | -197.22 | -25.81 | -586.18 | -61.21 | -40.77 |
| EBITDA | -19.74 Million | -19.6 Million | -21.4 Million | -28.05 Million | -31.61 Million | -28.9 Million |
| Earnings Before Tax Margin | -40.15 | -199.06 | -24.99 | -566.62 | -61.21 | -37.68 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 232 Thousand | 104 Thousand | 570 Thousand | -386 Thousand | 20 Thousand | - |
| Cost of Revenue | 25 Thousand | 27 Thousand | 119 Thousand | 26.5 Thousand | 31 Thousand | 30 Thousand |
| Gross Profit | 207 Thousand | 77 Thousand | 451 Thousand | -412.5 Thousand | -11 Thousand | -30 Thousand |
| Operating Expenses | 5.92 Million | 5.17 Million | 23.33 Million | 4.96 Million | 5.85 Million | 7.07 Million |
| Selling, General and Administrative Expenses | 2.08 Million | 1.79 Million | - | 1.63 Million | 1.49 Million | 2.02 Million |
| Research and Development Expenses | 3.83 Million | 3.38 Million | - | 3.33 Million | 4.35 Million | 5.05 Million |
| Other Expenses | 16 Thousand | -1000.00 | 912 Thousand | -52 Thousand | 922 Thousand | 17 Thousand |
| Cost and Expenses | 5.95 Million | 5.17 Million | 23.45 Million | 4.98 Million | 5.85 Million | 7.07 Million |
| Operating Income | -5.72 Million | -5.07 Million | -22.88 Million | -4.98 Million | -5.83 Million | -7.07 Million |
| Interest Expense | - | 28 Thousand | 1000.00 | 383 Thousand | - | - |
| Income Tax Expense | -5.74 Million | -27 Thousand | -48.89 Thousand | 38 Thousand | -31 Thousand | 17 Thousand |
| Earnings before Tax | -5.63 Million | -3.89 Million | -20.25 Million | -3.31 Million | -4.91 Million | -7.06 Million |
| Net Income | -5.63 Million | -3.89 Million | -20.25 Million | -3.31 Million | -4.91 Million | -7.06 Million |
| Earnings Per Share Basic | -3.10 | -2.94 | - | -3.29 | -15.26 | -25.20 |
| Earnings Per Share Diluted | -3.10 | -2.94 | - | -3.29 | -15.26 | -24.54 |
| Weighted Average Shares Outstanding | 1.81 Million | 1.32 Million | 463.65 Thousand | 1 Million | 321.91 Thousand | 280.15 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.81 Million | 1.32 Million | 463.65 Thousand | 1 Million | 321.91 Thousand | 287.72 Thousand |
| Gross Margin | 0.89 | 0.74 | 0.79 | 1.07 | -0.55 | - |
| EBIT Margin | -24.56 | -48.79 | - | 12.85 | -291.70 | - |
| Profit Margin | -24.27 | -37.47 | -35.53 | 8.59 | -245.60 | - |
| EBITDA | -5.69 Million | -5.07 Million | - | -4.96 Million | -5.83 Million | -7.03 Million |
| Earnings Before Tax Margin | -24.66 | -48.79 | -40.15 | 12.92 | -291.70 | - |
CFIC
AXDX
601168
ACKRF
UBSI
688625